A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer
Status:
Terminated
Trial end date:
2015-12-24
Target enrollment:
Participant gender:
Summary
This study is aimed to determine the tolerability of the PF-03084014 plus docetaxel
combination in patients with advanced breast cancer. Preliminary information about the
efficacy of the combination will also be collected.